Senior Scientist I, Cancer Immunology jobs in United States
cer-icon
Apply on Employer Site
company-logo

Revolution Medicines · 5 hours ago

Senior Scientist I, Cancer Immunology

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Senior Scientist I in Cancer Immunology will leverage their expertise to advance the company’s assets in preclinical and clinical development, conducting studies to support immuno-oncology biomarker plans and contributing to the understanding of tumor immunology.

Health CareLife ScienceMedical
check
H1B Sponsor Likelynote

Responsibilities

Design, develop, validate and execute in vitro, in vivo, and ex vivo studies to address key translational questions and support immuno-oncology biomarker plans
Identify, evaluate and implement emerging technologies to enhance translational biomarker discovery and mechanistic understanding
Drive reverse translation efforts by formulating and testing hypotheses derived from clinical finding as appropriate to inform clinical development plans
Stay abreast of advances in tumor immunology and immunotherapy, identifying novel combination strategies and contributing to preclinical evaluation
Analyze, interpret, and communicate complex data effectively across internal cross-functional teams and at external scientific meetings
Represent Revolution Medicines at scientific conferences and other external engagements

Qualification

Ph.D. in immunologyTumor immunology expertiseImmuno-oncology biomarkersVivo model designImmunology techniquesBiotech industry experienceHumanized mouse modelsMultiomics analysesProblem-solving skillsCommunication skills

Required

Ph.D. in immunology, cancer biology, or a related discipline, with deep expertise in tumor immunology, immuno-oncology biomarkers, and/or immunotherapy
Proven track record of research excellence, evidenced by high-impact publications
Expertise in in vivo model design to evaluate the efficacy and mechanisms of action of therapeutic agents and enable biomarker discovery, both internally and via contract research organizations
Strong technical expertise in immunology techniques including multi-parameter flow cytometric analyses, primary human cellular/tissue-based functional assays, cell biology and molecular biology to guide/inform mechanism of action and biomarker discovery
Strong problem-solving skills and ability to independently oversee scientific projects, rigorously analyze and interpret scientific data while maintaining attention to detail
Excellent written and verbal communication skills. Thrives in a fast-paced, collaborative, interdisciplinary team setting
4+ years of relevant biotech or pharmaceutical industry experience in oncology drug discovery and development

Preferred

Hands-on experience with humanized mouse models is desirable
Familiarity with multiomics analyses and integrating computational insights into experimental designs

Benefits

Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities

Company

Revolution Medicines

twittertwitter
company-logo
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.

H1B Sponsorship

Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)

Funding

Current Stage
Public Company
Total Funding
$2.25B
Key Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M

Leadership Team

leader-logo
Luan Wilfong
Chief Human Resources Officer
linkedin
leader-logo
Steve Kelsey
President
linkedin
Company data provided by crunchbase